Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
University of Nebraska
Adela, Inc
Cancer Research UK
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Tempus AI